Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial
Plain Language Summary The Bacillus Calmette–Guérin (BCG) vaccine has been studied previously in several settings, including reducing childhood mortalities due to viral infections and induction of trained immunity and reducing upper respiratory tract infections and pneumonia in older adults. This mu...
Main Authors: | Sanjeev Sinha, Anuj Ajayababu, Himanshu Thukral, Sushil Gupta, Subhasish Kamal Guha, Ayan Basu, Gaurav Gupta, Prashant Thakur, Raghavendra Lingaiah, Bimal Kumar Das, Urvashi B. Singh, Ravinder Singh, Rajiv Narang, Dipankar Bhowmik, Naveet Wig, Dolan Champa Modak, Bhaswati Bandyopadhyay, Banya Chakrabarty, Aditya Kapoor, Satyendra Tewari, Narayan Prasad, Zia Hashim, Alok Nath, Niraj Kumari, Ravinder Goswami, Shivam Pandey, Ravindra Mohan Pandey |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2022-10-01
|
Series: | Infectious Diseases and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40121-022-00703-y |
Similar Items
-
Correction to: Efficacy of Bacillus Calmette–Guérin (BCG) Vaccination in Reducing the Incidence and Severity of COVID-19 in High-Risk Population (BRIC): a Phase III, Multi-centre, Quadruple-Blind Randomised Control Trial
by: Sanjeev Sinha, et al.
Published: (2023-02-01) -
Effectiveness of Bacille Calmette-Guerin vaccination policies in reducing infection and mortality of COVID-19: a systematic review
by: Joseph Christian Obnial, et al.
Published: (2022-11-01) -
Covid 19 Vaccine - boon or a bane?
by: Kasturi Ravinder Reddy1 , Samkisha Earna2
Published: (2020-08-01) -
Will Bivalent Vaccination against COVID-19 Increase the Desire for COVID-19 Vaccination among Poles?
by: Mateusz Babicki
Published: (2022-10-01) -
India’s efforts to achieve 1.5 billion COVID-19 vaccinations: a narrative review
by: Kapil Singh, et al.
Published: (2022-10-01)